(Q46196659)

20 December 2017

editorial

0 references

review article

1 reference

title

Understanding racial differences in colorectal cancer aids in individualized medicine (English)

1 reference

20 December 2017

1 reference

Upender Manne

1

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

20 December 2017

published in

Future Oncology

1 reference

20 December 2017

volume

3

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

235-241

1 reference

20 December 2017

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Colorectal cancer model of health disparities: understanding mortality differences in minority populations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Emerging and widening colorectal carcinoma disparities between Blacks and Whites in the United States (1975-2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

p53 in colorectal cancer: clinicopathological correlation and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Multiple genetic alterations in distal and proximal colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Microsatellite instability in cancer of the proximal colon

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Anatomic site distribution of colon cancer by race and other colon cancer risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Variation in colorectal cancer incidence in the United States by subsite of origin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Incidence of colorectal adenocarcinoma by anatomic subsite. An epidemiologic study of time trends and racial differences in the Detroit, Michigan area.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Anatomical distribution of colonic carcinomas. Interracial differences in a community hospital population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

The relation of age, race, and gender to the subsite location of colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Oncogenic forms of p53 inhibit p53-regulated gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Determinants of black/white differences in colon cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Mutations of p53 gene in human colorectal tumor in Japan: molecular epidemiological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Restoration of p53 function leads to tumour regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Manipulation of the tumor suppressor p53 for potentiating cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Racial and ethnic disparities in the receipt of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Racial comparison of outcomes of male Department of Veterans Affairs patients with lung and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Current issues in adjuvant treatment of stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Adjuvant chemotherapy for stage II colorectal cancer: the time is right!

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

Impact of comorbidity on lung cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.3.235

21 January 2018

Identifiers

DOI

10.2217/14796694.3.3.235

1 reference

20 December 2017

1 reference

20 December 2017